Idorsia Ltd. (IDRSF)
5.65
-0.10
(-1.74%)
USD |
OTCM |
May 29, 16:00
Idorsia Profit Margin (Quarterly) : -162.1% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 15.02% |
| AC Immune SA | -1.32K% |
| CRISPR Therapeutics AG | -8.43K% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -25.87% |
| Return on Invested Capital | -103.3% |
| Gross Profit Margin (Quarterly) | 72.02% |
| Operating Margin (Quarterly) | -112.4% |
| Return on Net Operating Assets | -34.76% |